Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.
Open Access
- 1 March 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 138 (5) , 1464-1468
- https://doi.org/10.4049/jimmunol.138.5.1464
Abstract
Cytokines with bone-resorbing activity include IL 1 beta (pI 7), IL 1 alpha (pI 5), tumor necrosis factor (TNF), and lymphotoxin (LT). Possible interaction between IL 1 beta, the major mediator with osteoclast-activating factor (OAF) activity, and other cytokines was studied. By itself, IL 1 beta was 13-fold more potent than IL 1 alpha and 1000-fold more potent than either TNF or LT in stimulating bone resorption. Suboptimal concentrations of IL 1 beta or IL 1 alpha in combination with suboptimal concentrations of TNF or LT resulted in synergistic bone-resorptive responses (1.5 to 10 times the expected responses if their effects were additive). Synergy between either form of IL 1 and TNF or LT resulted in a twofold increase in activity of IL 1, and a 100-fold increase in activity of TNF or LT. However, even with optimal synergy, IL 1 beta remained 20-fold more potent in inducing bone resorption than TNF or LT. Because IL 1 beta is considerably more potent than TNF and LT in stimulating bone resorption either alone or under synergistic conditions, it is unlikely that TNF and LT are responsible for more than a minor proportion of the total bone-resorbing activity formerly referred to as OAF.This publication has 11 references indexed in Scilit:
- Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.The Journal of Immunology, 1986
- Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.The Journal of Immunology, 1985
- The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities.The Journal of Immunology, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- In vitro activation of human chondrocytes and synoviocytes by a human interleukin‐1‐like factorArthritis & Rheumatism, 1984
- Isolation of an interleukin‐1‐like factor from human joint effusionsArthritis & Rheumatism, 1983
- Increased thymocyte-activating factor in human gingival fluid during gingival inflammationInfection and Immunity, 1982
- N-acetyl muramyl dipeptide stimulation of bone resorption in tissue cultureInfection and Immunity, 1982
- Interactions between bacterial endotoxin and other stimulators of bone resorption in organ cultureJournal of Periodontal Research, 1981
- CHARACTERIZATION OF LYMPHOCYTE-ACTIVATING FACTOR (LAF) PRODUCED BY MACROPHAGE CELL LINE, P388D1 .1. ENHANCEMENT OF LAF PRODUCTION BY ACTIVATED T-LYMPHOCYTES1978